If Medicare Part D narrowly defines cardiovascular disease, the majority of patients would remain ineligible while new federal spending could still exceed $10 billion
Commercially available tests to identify Candida auris susceptibility perform poorly
Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision.
June 18, 2023